February 14, 2007Open Access
View Full PaperRandomized Trial of Pulsed Corticosteroid Therapy for Primary Treatment of Kawasaki Disease
Key Points
Key points are not available for this paper at this time.
Abstract
Our data do not provide support for the addition of a single pulsed dose of intravenous methylprednisolone to conventional intravenous immune globulin therapy for the routine primary treatment of children with Kawasaki disease. (ClinicalTrials.gov number, NCT00132080 ClinicalTrials.gov.)